Pace Myrna, van Sas Stijn, Salaets Thomas, Laenen Annouschka, Raaijmakers Anke, Allegaert Karel
Faculty of Medicine, KU Leuven, 3000 Leuven, Belgium.
Pediatric Cardiology, University Hospitals, 3000 Leuven, Belgium.
Children (Basel). 2025 Feb 13;12(2):231. doi: 10.3390/children12020231.
BACKGROUND/OBJECTIVES: Sodium regulation is critical in extremely low birth weight (ELBW, <1000 g) infants. This study aimed to provide a comprehensive overview of sodium dynamics and related variables in ELBW infants in their first 10 days of life through a structured literature review.
Applying PRISMA guidelines, six databases were searched (1 August 2023) on sodium measurements in ELBW cohorts, with quality assessment (RoB2, ROBINS-1, Newcastle Ottawa scale) of retained papers, and subsequent data extraction in line with these PRISMA guidelines to describe findings.
Only eight heterogeneous studies could be retained, including observational cohort studies (n = 5), case-control studies (n = 2, Tegaderm application yes/no, gestational age < 24 or 24-28 weeks), and only one randomized trial (sodium restriction versus no sodium restriction). Definitions of hyper- or hyponatremia were also heterogeneous, with incidence ranges for hyper- (8-92.2%) and hyponatremia (0-52.9%). Peak sodium values were observed on days 2-4 in the individual studies. When pooled and compared to the cohort mean sodium values, the highest increases in mean serum sodium values were observed on day 3 (+4, range, -0.6 to +8.6 mEq). Variables of sodium values were related to care factors [incubator settings (open/closed, double-/not double-walled, humidity), fluid regimens (water volume, sodium supplementation), occlusive skin care], as well as related maturational factors (postnatal age, gestational age, small versus appropriate for gestational age, SGA/AGA).
Based on a structured literature review, patterns of sodium changes over postnatal age in ELBW cases were documented. Besides incubator settings, fluid regimens, or occlusive skin care, these patterns also depend on maturational factors of the ELBW infant (gestational age, postnatal age, SGA/AGA). These complexities emphasize the need for nuanced interpretation, the relevance of standardizing clinical practices and research definitions, and the need to report on additional datasets.
背景/目的:钠调节在极低出生体重(ELBW,<1000克)婴儿中至关重要。本研究旨在通过结构化文献综述全面概述ELBW婴儿出生后前10天的钠动态及相关变量。
应用PRISMA指南,检索了六个数据库(2023年8月1日)中关于ELBW队列中钠测量的研究,对纳入的论文进行质量评估(RoB2、ROBINS - 1、纽卡斯尔渥太华量表),随后根据这些PRISMA指南进行数据提取以描述研究结果。
仅保留了八项异质性研究,包括观察性队列研究(n = 5)、病例对照研究(n = 2,应用皮肤保护膜与否,胎龄<24周或24 - 28周),且仅有一项随机试验(钠限制与无钠限制)。高钠血症或低钠血症的定义也存在异质性,高钠血症的发生率范围为8% - 92.2%,低钠血症为0% - 52.9%。在各项研究中,钠峰值出现在第2 - 4天。当汇总并与队列平均钠值比较时,第3天观察到平均血清钠值升高幅度最大(+4,范围为 - 0.6至 +8.6 mEq)。钠值变量与护理因素[暖箱设置(开放/封闭、双层/非双层壁、湿度)、液体疗法(水量、钠补充)、皮肤封闭护理]以及相关成熟因素(出生后年龄、胎龄、小于胎龄儿与适于胎龄儿,SGA/AGA)有关。
基于结构化文献综述,记录了ELBW病例中钠随出生后年龄变化的模式。除了暖箱设置、液体疗法或皮肤封闭护理外,这些模式还取决于ELBW婴儿的成熟因素(胎龄、出生后年龄、SGA/AGA)。这些复杂性强调了进行细致解读的必要性、规范临床实践和研究定义的相关性以及报告额外数据集的必要性。